161 related articles for article (PubMed ID: 35261781)
1. Upregulation of Cyclin B2 (
Aljohani AI; Toss MS; El-Sharawy KA; Mirza S; Ball GR; Green AR; Rakha EA
Am J Cancer Res; 2022; 12(2):469-489. PubMed ID: 35261781
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development.
Aljohani AI; Toss MS; Green AR; Rakha EA
Breast Cancer Res Treat; 2023 Apr; 198(3):423-435. PubMed ID: 36418517
[TBL] [Abstract][Full Text] [Related]
3. The expression of high mobility group protein 3 (
Aljohani AI; Alsaeed SA; Toss MS; Raafat SA; Green AR; Rakha EA
Am J Cancer Res; 2023; 13(11):5334-5351. PubMed ID: 38058796
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.
Aljohani AI; Toss MS; Kurozumi S; Joseph C; Aleskandarany MA; Miligy IM; Ansari RE; Mongan NP; Ellis IO; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jan; 179(1):79-90. PubMed ID: 31599393
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer.
Kariri YA; Joseph C; Alsaleem MA; Elsharawy KA; Alsaeed S; Toss MS; Mongan NP; Green AR; Rakha EA
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428736
[TBL] [Abstract][Full Text] [Related]
6. Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer.
Aleskandarany MA; Sonbul SN; Mukherjee A; Rakha EA
Pathobiology; 2015 Sep; 82(3-4):113-23. PubMed ID: 26330352
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer.
Kariri YA; Alsaleem M; Joseph C; Alsaeed S; Aljohani A; Shiino S; Mohammed OJ; Toss MS; Green AR; Rakha EA
Breast Cancer Res Treat; 2021 Jan; 185(2):293-305. PubMed ID: 33073304
[TBL] [Abstract][Full Text] [Related]
8. A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.
Kurozumi S; Joseph C; Sonbul S; Alsaeed S; Kariri Y; Aljohani A; Raafat S; Alsaleem M; Ogden A; Johnston SJ; Aleskandarany MA; Fujii T; Shirabe K; Caldas C; Ashankyty I; Dalton L; Ellis IO; Desmedt C; Green AR; Mongan NP; Rakha EA
Br J Cancer; 2019 Jun; 120(12):1129-1136. PubMed ID: 31114020
[TBL] [Abstract][Full Text] [Related]
9. Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype.
Kariri YA; Aleskandarany MA; Joseph C; Kurozumi S; Mohammed OJ; Toss MS; Green AR; Rakha EA
Pathobiology; 2020; 87(4):218-231. PubMed ID: 32645698
[TBL] [Abstract][Full Text] [Related]
10. Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor Prognosis.
Li R; Jiang X; Zhang Y; Wang S; Chen X; Yu X; Ma J; Huang X
Arch Med Res; 2019 Jan; 50(1):10-17. PubMed ID: 31101236
[TBL] [Abstract][Full Text] [Related]
11. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics prediction and experimental verification identify MAD2L1 and CCNB2 as diagnostic biomarkers of rhabdomyosarcoma.
Xia T; Meng L; Zhao Z; Li Y; Wen H; Sun H; Zhang T; Wei J; Li F; Liu C
Cancer Cell Int; 2021 Nov; 21(1):634. PubMed ID: 34838000
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.
Asaoka M; Patnaik SK; Zhang F; Ishikawa T; Takabe K
Breast Cancer Res Treat; 2020 Jun; 181(2):309-322. PubMed ID: 32285241
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy.
Liu YL; Saraf A; Lee SM; Zhong X; Hibshoosh H; Kalinsky K; Connolly EP
Breast Cancer Res Treat; 2016 Jun; 157(3):555-64. PubMed ID: 27225388
[TBL] [Abstract][Full Text] [Related]
15. Identification of
Moradpoor R; Zali H; Gharebaghian A; Akbari ME; Ajdari S; Salimi M
Cell J; 2021 Sep; 23(4):406-413. PubMed ID: 34455715
[TBL] [Abstract][Full Text] [Related]
16. Cyclin B2 (CCNB2) Stimulates the Proliferation of Triple-Negative Breast Cancer (TNBC) Cells
Wu S; Su R; Jia H
Dis Markers; 2021; 2021():5511041. PubMed ID: 34354775
[TBL] [Abstract][Full Text] [Related]
17. The role of lymphovascular invasion as a prognostic factor in patients with lymph node-positive operable invasive breast cancer.
Song YJ; Shin SH; Cho JS; Park MH; Yoon JH; Jegal YJ
J Breast Cancer; 2011 Sep; 14(3):198-203. PubMed ID: 22031801
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.
Hamy AS; Lam GT; Laas E; Darrigues L; Balezeau T; Guerin J; Livartowski A; Sadacca B; Pierga JY; Vincent-Salomon A; Coussy F; Becette V; Bonsang-Kitzis H; Rouzier R; Feron JG; Benchimol G; Laé M; Reyal F
Breast Cancer Res Treat; 2018 Jun; 169(2):295-304. PubMed ID: 29374852
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.
Kurozumi S; Joseph C; Sonbul S; Gorringe KL; Pigera M; Aleskandarany MA; Diez-Rodriguez M; Nolan CC; Fujii T; Shirabe K; Kuwano H; Storr S; Martin SG; Ellis IO; Green AR; Rakha EA
Breast Cancer Res Treat; 2018 Aug; 170(3):525-533. PubMed ID: 29633055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
